Experiment-Based Interventions to Diabetic Retinopathy: Present and Advances

Area of Science:

• Ophthalmology
• Endocrinology
• Regenerative Medicine

Background:

• Diabetic retinopathy is a primary cause of vision loss in working-age adults, exacerbated by rising diabetes prevalence.
• The disease's pathophysiology involves metabolic-induced oxidative stress, inflammation, and neovascularization.
• Current treatments target symptoms like inflammation and angiogenesis but do not offer a radical cure.

Purpose of the Study:

• To review existing therapeutic strategies for diabetic retinopathy.
• To summarize novel cellular and genetic approaches for treating diabetic retinopathy.
• To evaluate the advantages and disadvantages of emerging therapies for fundamental disease remission.

Main Methods:

• Literature review of current and novel therapeutic strategies for diabetic retinopathy.
• Analysis of studies focusing on cellular and genetic techniques.
• Comparative assessment of treatment efficacy and limitations.

Main Results:

• Existing therapies manage inflammation, oxidation, and angiogenesis but lack curative effects.
• Novel cellular and genetic therapies are being explored for fundamental treatment.
• These advanced approaches aim to achieve disease remission at a core level.

Conclusions:

• Diabetic retinopathy remains a significant public health challenge requiring innovative solutions.
• Cellular and genetic therapies represent promising avenues for radical treatment of diabetic retinopathy.
• Further research is needed to fully establish the efficacy and safety of these novel approaches.